Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Goettingen – page 8

472 clinical trials in Goettingen, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Goettingen at a glance
472
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

472 trials in Goettingen

Open in trial search

A Study of Depemokimab Compared to Placebo in Adults with Chronic Obstructive Pulmonary Disease and Type 2 Inflammation

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Depemokimab
  • Sponsor:Glaxosmithkline Research & Development Limited

A Study of Puxitatug Samrotecan Compared to Chemotherapy for Patients with Advanced Endometrial Cancer After Previous Platinum and Immunotherapy Treatment

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:AZD8205
  • Sponsor:AstraZeneca AB

A study testing ninerafaxstat compared to placebo in patients with symptomatic non-obstructive hypertrophic cardiomyopathy

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Ninerafaxstat trihydrochloride monohydrate
  • Sponsor:Imbria Pharmaceuticals Inc.

Prostate cancer

Recruiting

A study of saruparib with radiotherapy and hormone therapy for men with high-risk prostate cancer who have a BRCA gene mutation

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Abiraterone Acetate
  • Sponsor:AstraZeneca AB

Testing dapagliflozin to slow kidney function decline in patients with autosomal dominant polycystic kidney disease

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years
  • Substances:Dapagliflozin
  • Sponsor:University Of Cologne

A Study Testing AOC 1020 to Improve Movement in Adults with Facioscapulohumeral Muscular Dystrophy

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Delpacibart braxlosiran
  • Sponsor:Avidity Biosciences Inc.

A Study of Belzutifan and Zanzalintinib Compared to Cabozantinib in Patients with Advanced Kidney Cancer that Returned After Previous Treatment

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Belzutifan
  • Sponsor:Merck Sharp & Dohme LLC

Study of Lisocabtagene Maraleucel as First Treatment for Adults with Primary Central Nervous System Lymphoma Who Cannot Have a Stem Cell Transplant

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Calcium Folinate
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Endometrial cancer+1

Recruiting

A study comparing BNT323 with chemotherapy in patients with HER2-expressing recurrent endometrial cancer who received previous treatment

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:DB-1303
  • Sponsor:BioNTech SE

Study of divarasib and pembrolizumab compared to standard chemotherapy in previously untreated KRAS G12C-mutated advanced non-small cell lung cancer

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Budesonide
  • Sponsor:F. Hoffmann-La Roche AG

Study of KarXT (trospium chloride and xanomeline tartrate) and KarX-EC (xanomeline tartrate) for cognitive impairment in mild to moderate Alzheimer's disease

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Trospium Chloride
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Study of IMVT-1402 in Adults with Mild to Severe Generalized Myasthenia Gravis

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Imeroprubart
  • Sponsor:Immunovant Sciences GmbH

Other cities in Germany

The busiest research cities in the country

All 505 cities in Germany

Clinical research in Goettingen

What the registry says about research in the country

01 Cardiovascular Diseases and Stroke Research

Clinical trials in Göttingen are exploring cardiovascular diseases and acute ischemic stroke, with a focus on improving outcomes in people at high risk of serious events.

  • Atherosclerotic cardiovascular disease
  • Elevated lipoprotein(a)
  • Acute ischemic stroke
  • Testing new approaches to reduce event risk and improve recovery after stroke

These studies aim to support better prevention, emergency treatment, and long-term protection against major vascular complications.

02 Neoplasms and Cancer Therapy

A strong group of trials in Göttingen is centered on breast cancer, colorectal cancer, and selected pediatric and head and neck tumors, reflecting active work in oncology.

  • Breast neoplasms
  • Metastatic colorectal cancer
  • High-risk neuroblastoma and childhood renal tumors
  • Evaluating new cancer treatments and combinations to improve survival and disease control

Researchers are also studying treatment response in advanced and recurrent disease, helping refine care for both adults and children.

03 Nervous System Diseases and Brain Health

Trials in nervous system diseases are examining both stroke recovery and chronic neurological conditions, including diseases that affect movement and cognition.

  • Alzheimer’s disease and mild cognitive impairment
  • Amyotrophic lateral sclerosis
  • Multifocal motor neuropathy
  • Testing therapies aimed at slowing decline, improving symptoms, and supporting brain function

This area includes work on diagnostic value, symptom relief, and longer-term safety in progressive neurologic disorders.

04 Eye Diseases

Research on eye diseases is addressing conditions that can gradually affect vision, especially disorders linked to aging and inflammation.

  • Geographic atrophy and age-related macular degeneration
  • Uveitic macular edema
  • Assessing whether new eye-directed therapies can slow damage and preserve sight

These studies are focused on protecting visual function and finding better ways to manage chronic retinal disease.

05 Immune System Diseases and Allergy

Trials in immune system diseases are looking at allergy-related conditions and immune-mediated disorders that can affect quality of life and daily functioning.

  • House dust mite-induced allergic rhinitis and rhinoconjunctivitis
  • Acute pharyngitis
  • Multifocal motor neuropathy
  • Evaluating symptom relief and longer-term control of immune-driven disease

The research includes both treatment-focused studies and efforts to improve everyday symptom management.

06 Respiratory Tract Diseases and Neonatal Lung Care

In the area of respiratory tract diseases, investigators are studying common upper-airway illness as well as breathing outcomes in very premature infants.

  • Acute pharyngitis
  • Respiratory distress syndrome in preterm infants
  • Improving symptom control and early respiratory support

These trials aim to make care more effective for both short-term infection symptoms and early-life lung health.

07 Hemic and Lymphatic Diseases and Pediatric Blood Cancer

Research in hemic and lymphatic diseases is centered on childhood blood cancers, with attention to outcomes and treatment response in difficult-to-treat settings.

  • Myeloid leukemia in children with Down syndrome
  • Standard risk ALK-positive anaplastic large cell lymphoma
  • Testing strategies that may improve cure rates and survival

These studies reflect an effort to refine pediatric oncology care while maintaining strong safety and effectiveness standards.

08 Digestive System Diseases and Inflammatory Complications

Trials in digestive system diseases include supportive care for treatment-related bowel injury and painful inflammatory episodes.

  • Acute radiation proctitis
  • Gout and acute gout attack
  • Evaluating symptom relief and better control of inflammation-related discomfort

The studies are aimed at improving quality of life for patients dealing with gastrointestinal and inflammatory symptoms.

09 Male Urogenital Diseases and Prostate Cancer Supportive Care

Work in male urogenital diseases includes research on complications associated with treatment for prostate cancer, especially bowel side effects after radiation.

  • Prostate carcinoma
  • Acute radiation proctitis symptoms
  • Testing treatments that may reduce discomfort during cancer care

These trials focus on easing treatment burden and improving patient comfort during recovery.

10 Musculoskeletal Diseases and Movement Disorders

Several studies are investigating musculoskeletal diseases and related muscle disorders that affect strength, movement, and daily activity.

  • Myotonic dystrophy type 1 and type 2
  • Non-dystrophic myotonias
  • Gout
  • Assessing therapies that may improve muscle symptoms and reduce pain

This research area includes efforts to make symptom control more consistent for chronic neuromuscular conditions.

11 Psychiatry and Psychology

Clinical research in psychiatry and psychology is represented mainly through studies of cognitive decline and early dementia, where mental function and daily independence are key concerns.

  • Alzheimer’s disease
  • Newly diagnosed early-to-mild dementia
  • Mild cognitive impairment
  • Evaluating treatments intended to support cognition and slow worsening

These trials are designed to better understand disease progression and strengthen care options for patients and families.

12 Otorhinolaryngologic Diseases

Studies in otorhinolaryngologic diseases are addressing upper-airway and throat complaints, with an emphasis on easing bothersome symptoms.

  • Acute pharyngitis
  • Allergic rhinoconjunctivitis
  • Testing symptom-relief approaches for common ear, nose, and throat conditions

This line of research aims to improve comfort and day-to-day function for patients with frequent ENT problems.

13 Eye and Immune-Related Inflammation

Some trials bridge eye disease and immune-mediated inflammation, especially where swelling or tissue damage can threaten vision.

  • Uveitic macular edema
  • Geographic atrophy
  • Testing treatments that may preserve retinal structure and visual performance

These studies are focused on slowing progression and improving long-term eye health.

14 Unspecified and Cross-Cutting Research

Some clinical trials in Göttingen span more than one therapeutic area, bringing together cardiovascular, neurological, oncology, and rare disease research under broader care questions.

  • Acute ischemic stroke
  • Breast cancer and colorectal cancer
  • Alzheimer’s disease and myotonic disorders
  • Exploring whether new or combined treatments can improve outcomes across complex disease settings

This mix highlights a broad and active research environment with multiple specialties contributing to patient care.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.